Clinical Trial Update: A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating ritonavir-boosted danoprevir in combination with peginterferon alfa-2a and ribavirin in Asian-origin patients with chronic hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Danoprevir (danoprevir)
• Pegasys (pegylated interferon alfa-2a)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED